by Richard Daverman, PhD
May 28, 2014 -- MicroPort Scientific of Shanghai and Italy’s Sorin Group reported that their $20 million China medical device JV received official regulatory approval. The JV, which was announced in January, will develop its own CRM devices and also import Sorin’s cardiac rhythm devices for China. MicroPort will invest $10.2 million in the JV for a 51% stake; Sorin will contribute the remainder. Operations are scheduled to begin next month. More details....
Stock Symbols: (HK: 00853) (MIL: SRN)
Help employers find you! Check out all the jobs and post your resume.
